Skip to content

BMRN

BioMarin Pharmaceutical Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$3.7B+11.6%
Gross profit$2.8B+13.4%
Operating income$114M—
Net income−$19M−16.4%
EPS−$0.08−16.7%
Free cash flow$558M—